Picture of Hofseth Biocare ASA logo

HBC Hofseth Biocare ASA News Story

0.000.00%
no flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapSucker Stock

Brief: Hofseth Biocare: Two-Year Research Collaboration Contract Signed With Stanford

May 11 (Reuters) - Hofseth Biocare ASA  HOFBC.OL :
    * REG-HOFSETH BIOCARE ASA: TWO-YEAR RESEARCH COLLABORATION
CONTRACT SIGNED WITH STANFORD ON THE USE OF SALMON PROTEIN
HYDROLYSATE PEPTIDES FOR THE TREATMENT OF GI TRACT DISEASES IN
CHILDREN AND ADULTS
    * FOCUS OF COLLABORATION IS TO FURTHER ELUCIDATE HOW SPH
REDUCES
OR PREVENTS INTESTINAL INFLAMMATION IN PRECLINICAL MODELS OF NEC

Source text for Eikon:  ID:nGNEby18wb 
Further company coverage:  HOFBC.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Hofseth Biocare ASA

See all news